Across TCGA pan-cancer cohorts, TAF13P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of TAF13P2’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where TAF13P2 RNA is repressed in tumor relative to normal tissue. In most cancer types TAF13P2 is over-expressed in tumor, although a few such as PAAD and LUAD show the opposite, repressed pattern.

PAAD, LUAD, and BLCA are the cancer types where TAF13P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TAF13P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.425	.006	2	view →
LUAD	Female	II,III,IV	−0.240	.010	1	view →
BLCA	All	III,IV	+0.172	.048	1	view →
KICH	Male	All	+0.097	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: TAF13P2 RNA expression & survival · all TAF13P2 data types